These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30213277)

  • 1. Correction to: Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling.
    Hu F; Li H; Liu L; Xu F; Lai S; Luo X; Hu J; Yang X
    Mol Cancer; 2018 Sep; 17(1):135. PubMed ID: 30213277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling.
    Hu F; Li H; Liu L; Xu F; Lai S; Luo X; Hu J; Yang X
    Mol Cancer; 2018 Jul; 17(1):107. PubMed ID: 30060750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent metabolic reprogramming.
    Sun S; Liu J; Zhao M; Han Y; Chen P; Mo Q; Wang B; Chen G; Fang Y; Tian Y; Zhou J; Ma D; Gao Q; Wu P
    Cell Death Dis; 2019 Sep; 10(10):707. PubMed ID: 31548594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Corrigendum] c‑Myc regulates the CDK1/cyclin B1 dependent‑G2/M cell cycle progression by histone H4 acetylation in Raji cells.
    Yang Y; Xue K; Li Z; Zheng W; Dong W; Song J; Sun S; Ma T; Li W
    Int J Mol Med; 2019 Nov; 44(5):1988. PubMed ID: 31432156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Author Correction: Macrophages confer resistance to PI3K inhibitor GDC-0941 in breast cancer through the activation of NF-κB signaling.
    Usman MW; Gao J; Zheng T; Rui C; Li T; Bian X; Cheng H; Liu P; Luo F
    Cell Death Dis; 2019 Jun; 10(7):501. PubMed ID: 31235854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Author Correction: Caveolin-1 promotes invasion and metastasis by upregulating Pofut1 expression in mouse hepatocellular carcinoma.
    Zhang C; Huang H; Zhang J; Wu Q; Chen X; Huang T; Li W; Liu Y; Zhang J
    Cell Death Dis; 2019 Jul; 10(8):572. PubMed ID: 31358729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction to: The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.
    Zheng L; Li X; Gu Y; Lv X; Xi T
    Breast Cancer Res Treat; 2020 Jan; 179(2):521-522. PubMed ID: 31655919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Author Correction: SZT2 dictates GATOR control of mTORC1 signalling.
    Peng M; Yin N; Li MO
    Nature; 2018 Jun; 558(7710):E2. PubMed ID: 29769712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Author Correction: Linc-DYNC2H1-4 promotes EMT and CSC phenotypes by acting as a sponge of miR-145 in pancreatic cancer cells.
    Gao Y; Zhang Z; Li K; Gong L; Yang Q; Huang X; Hong C; Ding M; Yang H
    Cell Death Dis; 2019 Aug; 10(8):604. PubMed ID: 31406116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction to: FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer.
    Lai H; Zhao X; Qin Y; Ding Y; Chen R; Li G; Labrie M; Ding Z; Zhou J; Hu J; Ma D; Fang Y; Gao Q
    J Exp Clin Cancer Res; 2019 Oct; 38(1):415. PubMed ID: 31615580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.
    Hutcheson IR; Knowlden JM; Hiscox SE; Barrow D; Gee JMW; Robertson JF; Ellis IO; Nicholson RI
    Breast Cancer Res; 2018 Aug; 20(1):98. PubMed ID: 30165904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-dependent chromatin localization of KDM4D lysine demethylase promotes H3K9me3 demethylation.
    Zoabi M; Nadar-Ponniah PT; Khoury-Haddad H; Usaj M; Budowski-Tal I; Haran T; Henn A; Mandel-Gutfreund Y; Ayoub N
    Nucleic Acids Res; 2014 Dec; 42(21):13026-38. PubMed ID: 25378304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression.
    Su TP; Chen MH; Li CT; Lin WC; Hong CJ; Gueorguieva R; Tu PC; Bai YM; Cheng CM; Krystal JH
    Neuropsychopharmacology; 2019 Feb; 44(3):655-656. PubMed ID: 30487654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction to: The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells.
    Shapira M; Kakiashvili E; Rosenberg T; Hershko DD
    Breast Cancer Res; 2018 Jul; 20(1):68. PubMed ID: 29986739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Targeting Leptin as a Therapeutic Strategy against Ovarian Cancer Peritoneal Metastasis.
    Wei X; Liu Y; Gong C; Ji T; Zhou X; Zhang T; Wan D; Xu S; Jin P; Yang X; Li X; Ma D; Yang Z; Gao Q
    Anticancer Agents Med Chem; 2019; 19(1):140-142. PubMed ID: 31204622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction to: Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
    Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
    Breast Cancer Res; 2018 Jul; 20(1):63. PubMed ID: 29966525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome.
    Stylianou N; Lehman ML; Wang C; Fard AT; Rockstroh A; Fazli L; Jovanovic L; Ward M; Sadowski MC; Kashyap AS; Buttyan R; Gleave ME; Westbrook TF; Williams ED; Gunter JH; Nelson CC; Hollier BG
    Oncogene; 2019 Mar; 38(13):2436. PubMed ID: 30510231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of pyrazolo[1,5-a]pyrimidine-3-carbonitrile derivatives as a new class of histone lysine demethylase 4D (KDM4D) inhibitors.
    Fang Z; Wang TQ; Li H; Zhang G; Wu XA; Yang L; Peng YL; Zou J; Li LL; Xiang R; Yang SY
    Bioorg Med Chem Lett; 2017 Jul; 27(14):3201-3204. PubMed ID: 28539219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction to: Different apoptotic effects of saxifragifolin C in human breast cancer cells.
    Kim KH; Kim JY; Kwak JH; Kim BO; Pyo S
    Arch Pharm Res; 2019 Apr; 42(4):373-374. PubMed ID: 30467625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Corrigendum] Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma.
    Yang W; Wang X; Zheng W; Li K; Liu H; Sun Y
    Int J Oncol; 2017 Jan; 50(1):340. PubMed ID: 27779677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.